site stats

Biotheranostics stock

WebJan 6, 2024 · Biotheranostics is a privately-held company that sells molecular diagnostics tests for breast and metastatic cancers. Hologic said the company generated about $33 … WebJan 6, 2024 · January 6, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it agreed to acquire molecular diagnostic test maker Biotheranostics for approximately $230 million. Privately held, …

Theranos - Wikipedia

WebApr 1, 2024 · Stock quotes by finanzen.net Two crossed lines that form an 'X'. ... Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting … WebFeb 23, 2024 · February 23, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last ... pheifer construction https://prime-source-llc.com

Hologic : to Acquire Biotheranostics, Leader in Molecular Tests …

WebNot Registered? Click here to start the process.. Loading WebJan 5, 2024 · SPX. +1.87%. Medical technology company Hologic Inc. HOLX, +0.71% said late Tuesday it has agreed to buy privately held Biotheranostics Inc. for $230 million. Biotheranostics, which generated ... WebBeing part of Hologic only helps bring that hope closer to reality. In addition, patients facing the challenges of metastatic cancer will have broader access to our CancerTYPE ID … pheifer bros

Biotheranostics - Crunchbase Company Profile

Category:DISCLOSURE OF FINANCIAL RELATIONSHIPS

Tags:Biotheranostics stock

Biotheranostics stock

Hologic (HOLX) to Expand in Oncology With Biotheranostics …

WebLucile ; Healios, Ryne Bio . IC, IC : Program Committee, Speaker Agudo . Judith : No Relationships . Speaker . Ahn Jiyoung No Relationships Speaker WebBiotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. The company is based in San Diego, CA and offers testing se rvices through its CLIA-certified, CAP-accredited laboratory that is directly ...

Biotheranostics stock

Did you know?

WebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing … Web2 days ago · All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...

WebMar 11, 2024 · News for Hologic Stock (HOLX) Hologic Stock Sees Composite Rating Climb To Lofty 96. Investors Business Daily • 03/17/21. Top-Rated Stocks: Hologic Sees Composite Rating Climb To 96 ... Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market. Business Wire • 02/22/21. Is Hologic … WebFeb 22, 2024 · - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: …

WebTheranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014. The … WebCompany profile page for BioTheranostics Inc including stock price, company news, press releases, executives, board members, and contact information

WebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in oncology. Visit Hologic.com . Biotheranostics Nondiscrimination Notice. Download our PDF to view this notice in …

WebOct 29, 2024 · San Diego, CA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biotheranostics announces the publication of results from the IDEAL study in Clinical Cancer Research which reports novel findings of the Breast ... pheigw web consoleWebJan 5, 2024 · Biotheranostics is a leader in the development of evidence-based biomarkers to address unmet medical needs, and the company has set the foundation … pheiffer v dotWebJan 19, 2024 · Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. ... The bank suspended its … pheiffer hemingham house piggott arWebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. … pheiho massager how to useWebJan 5, 2024 · SPX. +1.87%. Medical technology company Hologic Inc. HOLX, +0.71% said late Tuesday it has agreed to buy privately held Biotheranostics Inc. for $230 million. … pheiffersWebJan 6, 2024 · Ana Baraulia - stock.adobe.com. The Marlborough, MA-based company said it would acquire Biotheranostics for $230 million. Omar Ford Jan 06, 2024. ... Biotheranostics generated about $33 … pheilciaWebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In … pheiho rechargeable massager directions